Stefano De Servi

Showing 1-11 of 11 articles

Coronary interventions

Use of low-dose prasugrel vs. clopidogrel in elderly patients with high clinical and PCI complexity.

Montalto C, Crimi G, Savonitto S, De Servi S

December 23, 2019 | 10.4244/EIJ-D-19-00859

Impact of sex on comparative outcomes of bivalirudin versus unfractionated heparin in patients with acute coronary syndromes undergoing invasive management: a pre-specified analysis of the MATRIX trial

Gargiulo G, Pasquetto G, Brugaletta S, Ferrari F, Casu G, Guiducci V, Dellavalle A, Liistro F, Mauro C, van't Hof A, Omerovic E, Curello S, de la Torre Hernandez J, De Servi S, Belloni F, Windecker S, Penzo C, Colombo A, da Costa B, Frigoli E, Palmieri C, Nazzaro M, Falcone C, Liso A, Vigna C, Abate F, Comeglio M, Diletti R, Gabrielli G, Di Lorenzo E, Mazzarotto P, Zimarino M, Moretti C, Valgimigli M

June 12, 2019 | 10.4244/EIJ-D-18-00247

Coronary interventions

Incidence and outcome of switching of oral platelet P2Y12 receptor inhibitors in patients with acute coronary syndromes undergoing percutaneous coronary intervention: the SCOPE registry

De Luca L, D’ascenzo F, Musumeci G, Saia F, Parodi G, Varbella F, Marchese A, De Servi S, Berti S, Bolognese L

July 20, 2017 | 10.4244/EIJ-D-17-00092

Coronary interventions

Relationship between diabetes, platelet reactivity, and the SYNTAX score to one-year clinical outcome in patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention

De Servi S, Crimi G, Calabrò P, Piscione F, Cattaneo M, Maffeo D, Toso A, Bartorelli A, Palmieri C, De Carlo M, Capodanno D, Barozzi C, Tomasi L, Della Riva D, Angiolillo D, Palmerini T

June 20, 2016 | 10.4244/EIJV12I3A51

Cystatin C and risk of mortality among patients undergoing percutaneous coronary intervention

Angeli F, Verdecchia P, Savonitto S, Arraiz G, Zaninotto M, Broccatelli A, Cosma C, De Servi S, Sabino F, Briguori C, Ambrosio G, Cavallini C

November 20, 2015 | 10.4244/EIJY14M08_02

CoreValve implantation for severe aortic regurgitation: a multicentre registry

Testa L, Latib A, Rossi M, De Marco F, De Carlo M, Fiorina C, Oreglia J, Petronio A, Ettori F, De Servi S, Klugmann S, Ussia G, Tamburino C, Panisi P, Brambilla N, Colombo A, Presbitero P, Bedogni F

October 20, 2014 | 10.4244/EIJV10I6A127

Perioperative management of antiplatelet therapy in patients with coronary stents undergoing cardiac and non-cardiac surgery: a consensus document from Italian cardiological, surgical and anaesthesiological societies

Rossini R, Musumeci G, Visconti L, Bramucci E, Castiglioni B, De Servi S, Lettieri C, Lettino M, Piccaluga E, Savonitto S, Trabattoni D, Capodanno D, Buffoli F, Parolari A, Dionigi G, Boni L, Biglioli F, Valdatta L, Droghetti A, Bozzani A, Setacci C, Ravelli P, Crescini C, Staurenghi G, Pietro Scarone P, Francetti L, D’Angelo F, Gadda F, Comel A, Salvi L, Lorini L, Antonelli M, Bovenzi F, Cremonesi A, Angiolillo D, Guagliumi G

May 20, 2014 | 10.4244/EIJV10I1A8

Simplifying clinical risk prediction for percutaneous coronary intervention of bifurcation lesions: the case for the ACEF (age, creatinine, ejection fraction) score

Biondi-Zoccai G, Romagnoli E, Castagno D, Sheiban I, De Servi S, Tamburino C, Colombo A, Burzotta F, Presbitero P, Bolognese L, Paloscia L, Rubino P, Sardella G, Briguori C, Niccoli L, Franco G, Di Girolamo D, Piatti L, Greco C, Petronio A, Loi B, Benassi A, Patti A, Gaspardone A, Frati G, Sangiorgi G

July 27, 2012 | 10.4244/EIJV8I3A55

Safety and efficacy of biodegradable vs. durable polymer drug-eluting stents: evidence from a meta-analysis of randomised trials

Navarese E, Kubica J, Castriota F, Gibson M, De Luca G, Buffon A, Bolognese L, Margheri M, Andreotti F, Di Mario C, De Servi S

December 30, 2011 | 10.4244/EIJV7I8A155

Sheiban I, La Spina C, Cavallero E, Biondi-Zoccai G, Colombo F, Palmerini T, Marzocchi A, Tamburino C, Margheri M, Vecchi G, Sangiorgi G, Santarelli A, Bartorelli A, Briguori C, Vignali L, di Pede F, Ramondo A, Fantoni C, De Carlo M, Falsini G, Benassi A, Palmieri C, Filippone V, Sangiorgi D, De Servi S

February 25, 2010

Diabetic patients treated for unprotected left main coronary artery disease with drug eluting stents: a 3-year clinical outcome study. The Diabetes and Drug Eluting stent for LeFT main registry (D-DELFT)

Meliga E, Garcia-Garcia H, Valgimigli M, Chieffo A, Biondi-Zoccai G, O’ Maree A, Gonzalo N, Cook S, Cruz-Gonzalez I, Marra S, De Servi S, Palacios I, Windecker S, van Domburg R, Colombo A, Sheiban I, Serruys P

May 13, 2008

Latest news

NEW ISSUE

The transcaval and transcarotid in TAVI, studies on the IMPella device, BRS and more

Example of CTCA reconstruction in a patient

February 7, 2020

JAA

New ahead of print: Validation of ARC-HBR criteria

Yasushi Ueki

February 18, 2020

JAA

New this week: FFR & myocardial mass, Chordae tendinea Rupture & more

February 18, 2020

Trials Book

New Update: CULPRIT, NOBEL, IVUS-XPL, SAFARI-STEMI

(The Trials book is supported by Biotronik)

February 14, 2020

Guidance Papers

Guidelines, consensus & position papers

April 9, 2019

Editorial

New Editor-in-Chief editorial. EuroIntervention: Moving forward

Davide Capodanno

February 7, 2020

Editorial

EuroPCR, ESC 2020 - spotlight on “The Cutting Edge of Cardiology”

Robert Byrne

January 17, 2020

Stefano De Servi

Latest news

Coronary

Valvular disease

Heart failure

Peripheral

Hypertension

Stroke